These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 17640739)
1. Anandamide and Delta9-tetrahydrocannabinol directly inhibit cells of the immune system via CB2 receptors. Eisenstein TK; Meissler JJ; Wilson Q; Gaughan JP; Adler MW J Neuroimmunol; 2007 Sep; 189(1-2):17-22. PubMed ID: 17640739 [TBL] [Abstract][Full Text] [Related]
2. Cannabinoids and the human uterus during pregnancy. Dennedy MC; Friel AM; Houlihan DD; Broderick VM; Smith T; Morrison JJ Am J Obstet Gynecol; 2004 Jan; 190(1):2-9; discussion 3A. PubMed ID: 14749627 [TBL] [Abstract][Full Text] [Related]
3. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. Anikwue R; Huffman JW; Martin ZL; Welch SP J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Lay L; Angus JA; Wright CE Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647 [TBL] [Abstract][Full Text] [Related]
5. Anandamide effects on 5-HT(3) receptors in vivo. Rácz I; Bilkei-Gorzo A; Markert A; Stamer F; Göthert M; Zimmer A Eur J Pharmacol; 2008 Oct; 596(1-3):98-101. PubMed ID: 18775693 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. Herradón E; Martín MI; López-Miranda V Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831 [TBL] [Abstract][Full Text] [Related]
7. Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice. Haller VL; Cichewicz DL; Welch SP Eur J Pharmacol; 2006 Sep; 546(1-3):60-8. PubMed ID: 16919265 [TBL] [Abstract][Full Text] [Related]
8. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221 [TBL] [Abstract][Full Text] [Related]
9. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Shivachar AC; Martin BR; Ellis EF Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904 [TBL] [Abstract][Full Text] [Related]
10. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800 [TBL] [Abstract][Full Text] [Related]
11. Effect of cannabinoids upon the uptake of folic acid by BeWo cells. Araújo JR; Gonçalves P; Martel F Pharmacology; 2009; 83(3):170-6. PubMed ID: 19145103 [TBL] [Abstract][Full Text] [Related]
12. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates. Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191 [TBL] [Abstract][Full Text] [Related]
13. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Pertwee RG Addict Biol; 2008 Jun; 13(2):147-59. PubMed ID: 18482430 [TBL] [Abstract][Full Text] [Related]
14. 2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL-60 cells. Kishimoto S; Kobayashi Y; Oka S; Gokoh M; Waku K; Sugiura T J Biochem; 2004 Apr; 135(4):517-24. PubMed ID: 15115777 [TBL] [Abstract][Full Text] [Related]
15. The effects of Delta9-tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide. O'Sullivan SE; Kendall DA; Randall MD Br J Pharmacol; 2005 Jun; 145(4):514-26. PubMed ID: 15821751 [TBL] [Abstract][Full Text] [Related]
16. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta. O'Sullivan SE; Kendall DA; Randall MD Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. Rao GK; Zhang W; Kaminski NE J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196 [TBL] [Abstract][Full Text] [Related]
18. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. Cencioni MT; Chiurchiù V; Catanzaro G; Borsellino G; Bernardi G; Battistini L; Maccarrone M PLoS One; 2010 Jan; 5(1):e8688. PubMed ID: 20098669 [TBL] [Abstract][Full Text] [Related]
19. Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. Molina-Holgado F; Molina-Holgado E; Guaza C; Rothwell NJ J Neurosci Res; 2002 Mar; 67(6):829-36. PubMed ID: 11891798 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Wiley JL; LaVecchia KL; Karp NE; Kulasegram S; Mahadevan A; Razdan RK; Martin BR Exp Clin Psychopharmacol; 2004 Aug; 12(3):173-9. PubMed ID: 15301634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]